Commercial Influence on Political Declarations: The Crucial Distinction Between Consultation and Negotiation and the Need for Transparency in Lobbying; Comment on “Competing Frames in Global Health Governance: An Analysis of Stakeholder Influence on the Political Declaration on Non-Communicable Diseases”

Document Type : Commentary


Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany


Suzuki and colleagues’ rare and elaborate analysis of the political processes behind the 2018 United Nations (UN) non- communicable diseases (NCD) Declaration discloses various pathways towards influencing global public health policies. Their study should be a wake-up call for further scientific political scrutiny and analysis, including clearly distinguishing between consultations such as UN multi-stakeholder hearings preceding high-level meetings and the actual negotiating and decision making process. While stakeholder positions at interactive hearings are documented and published and thus made transparent, the negotiating process among member states is not publicly known. The extent to which intergovernmental negotiations are influenced at country or regional levels by commercial interests through direct and indirect lobbying outside of public consultations should be given more attention. Lobby registers should be implemented more stringently and legislative footprints required and applied not only to legally binding but also to internationally important documents such as political declarations.


  1. Suzuki M, Webb D, Small R. Competing frames in global health governance: an analysis of stakeholder influence on the political declaration on non-communicable diseases. Int J Health Policy Manag. 2021. doi:34172/ijhpm.2020.257
  2. Moodie R, Stuckler D, Monteiro C, et al. Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries. Lancet. 2013;381(9867):670-679. doi:1016/s0140-6736(12)62089-3
  3. UN General Assembly. Political declaration of the 3rd High-Level Meeting of the General Assembly on the Prevention and Control of Non-Communicable Diseases. Accessed July 27, 2021. Published October 17, 2018.
  4. Gostin LO, Abou-Taleb H, Roache SA, Alwan A. Legal priorities for prevention of non-communicable diseases: innovations from WHO's Eastern Mediterranean region. Public Health. 2017;144:4-12. doi:1016/j.puhe.2016.11.001
  5. Pingeot L. Corporate Influence in the Post-2015 Process. Working Paper. Misereor–GPF–Brot Fur Die Welt; 2014.
  6. UN General Assembly. Political Declaration on HIV and AIDS: On the Fast Track to Accelerating the Fight against HIV and to Ending the AIDS Epidemic by 2030. Resolution adopted by the General Assembly on 8 June 2016. Published June 22, 2016.
  7. Ulucanlar S, Fooks GJ, Gilmore AB. The policy dystopia model: an interpretive analysis of tobacco industry political activity. PLoS Med. 2016;13(9):e1002125. doi:1371/journal.pmed.1002125
  8. Tangcharoensathien V, Chandrasiri O, Kunpeuk W, Markchang K, Pangkariya N. Addressing NCDs: challenges from industry market promotion and interferences. Int J Health Policy Manag. 2019;8(5):256-260. doi:15171/ijhpm.2019.02
  9. Reich MR. Essential drugs: economics and politics in international health. Health Policy. 1987;8(1):39-57. doi:1016/0168-8510(87)90129-1
  10. Quick JD, Hogerzeil HV, Velásquez G, Rägo L. Twenty-five years of essential medicines. Bull World Health Organ. 2002;80(11):913-914.
  11. Keeling S, Feeney S, Hogan J. Transparency! Transparency? comparing the new lobbying legislation in Ireland and the UK. Int Groups Adv. 2017;6(2):121-142. doi:1057/s41309-017-0015-z
  12. Obholzer L. A Call to Members of the European Parliament: Take Transparency Seriously and Enact the ‘Legislative Footprint.’ CEPS Policy Brief (No. 256). 2011.
  13. Patterson D, Buse K, Magnusson R, Toebes B. Identifying a human rights-based approach to obesity for States and civil society. Obes Rev. 2019;20 Suppl 2:45-56. doi:1111/obr.12873
Volume 11, Issue 7
July 2022
Pages 1219-1221
  • Receive Date: 02 August 2021
  • Revise Date: 07 September 2021
  • Accept Date: 10 September 2021
  • First Publish Date: 11 September 2021